in our free newsletter.

Thousands benefit from our email every week.

1. Pfizer (PFE)

A Pfizer COVID-19 vaccine vial
Marco Lazzarini / Shutterstock

It was just last week that BMO Capital initiated an “outperform” rating for pharmaceutical giant Pfizer, signaling that the company could outdo many competitors next year.

Pfizer’s share price is hovering around $53. BMO has projected it to hit $60.

Pfizer’s vaccine business is the obvious draw here, with COVID-generated revenue likely to continue rolling in over the next year. But the company’s solid financials and pipeline of new products should help it maintain the momentum it has built this year.

Pfizer just wrapped up a wild third quarter that saw revenues hit $24.1 billion — 134% higher than during the same period last year.

Year-to-date, Pfizer stock has risen 44%. It’s gained over 4% in the last week alone.

Fine wine is a sweet comfort in any situation — and now it can make your investment portfolio a little more comfortable, too. Now a platform called Vinovest helps everyday buyers invest in fine wines — no sommelier certification required.

Invest Now

2. Palo Alto Networks (PANW)

Palo Alto Networks logo on the side of an office building
Michael Vi / Shutterstock

BMO already bestowed an “outperform” rating on Palo Alto Networks after the cybersecurity firm released its Q1 earnings. Not only does that rating still hold, but BMO recently raised its price target for the company from $560 to $615.

Everything seems to be trending in the right direction for the company.

Its Q3 revenue beat analyst expectations by about $50 million, and was 28% higher year over year. Inflation has allowed Palo Alto to increase prices, and the steady growth of the cloud computing space means an increasing number of businesses should require its technology.

Palo Alto Networks is projecting revenue of around $5.3 billion for 2022. That rosy outlook has helped lift the company’s share price by about 48% since Aug. 23.

3. Alphabet (GOOGL)

Colorful bicycles outside a Google office building
Uladzik Kryhin / Shutterstock

Similar to Palo Alto Networks, BMO had already identified Alphabet, Google’s parent company, as an “outperform” candidate prior to the release of its third quarter earnings report. BMO then swiftly upped its target price for Alphabet from $3,000 to $3,200 per share.

Alphabet’s Q3 performance was predictably colossal. The $18.9 billion in profit marked the company’s fifth record-breaking quarter in a row. The revenue brought in during the third quarter, $65.1 billion, was almost $19 billion higher than in the same period last year.

Revenue from search and YouTube advertising continues to rise, as does the cash coming in from Google Cloud. Alphabet makes it difficult for investors to know how its Pixel phones and Android operating system are faring among consumers, but when your profits are increasing by 69% year over year, there’s not much reason to nitpick.

Fine wine is a sweet comfort in any situation — and now it can make your investment portfolio a little more comfortable, too. Now a platform called Vinovest helps everyday buyers invest in fine wines — no sommelier certification required.

Invest Now

Even if the market grows, this investment might grow faster

A man views framed artwork at a gallery holding a flute of champagne
SeventyFour / Shutterstock

No one really knows if the stock market is going to continue barreling ahead. It could run out of steam tomorrow.

Either way, now might be the time to consider diversifying your portfolio with real assets, which can insulate you from market turmoil and inflation.

One of those assets taking up increasing space in modern portfolios is contemporary art, which has outperformed the S&P 500 almost every year since 1995.

You don’t need millions of dollars to invest in rapidly appreciating works by artists like Banksy, Andy Warhol or Jean-Michel Basquiat, whose never-seen-before painting owned by rapper Jay-Z was the backdrop of his recent Tiffany & Co. ad with Beyonce.

A popular new app allows you to purchase shares in a variety of masterpieces for a fraction of the cost.

Get a piece of commercial real estate

Enhance your portfolio with high-return commercial real estate

First National Realty Partners is the #1 option for accredited investors seeking superior risk-adjusted returns in the grocery-anchored necessity-based retail space.

While commercial real estate has always been reserved for a few elite investors, outperforming the S&P 500 over a 25-year period, First National Realty Partners allows you to access institutional-quality commercial real estate investments — without the leg work of finding deals yourself.

Invest with First National Realty Partners now.

What to Read Next


The content provided on Moneywise is information to help users become financially literate. It is neither tax nor legal advice, is not intended to be relied upon as a forecast, research or investment advice, and is not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. Tax, investment and all other decisions should be made, as appropriate, only with guidance from a qualified professional. We make no representation or warranty of any kind, either express or implied, with respect to the data provided, the timeliness thereof, the results to be obtained by the use thereof or any other matter.